Tag: safety surveillance

Biosimilar Safety Monitoring: How Adverse Events Are Tracked and Managed

Biosimilars aren't like generics. They need special safety monitoring due to their complex structure. This article explains how adverse events are tracked, challenges in reporting, and how regulators are adapting. Real-world examples and future improvements in biosimilar safety surveillance.